REGN logo

REGN Net income

annual net income:

$4.41B+$459.00M(+11.61%)
December 31, 2024

Summary

  • As of today (May 29, 2025), REGN annual net profit is $4.41 billion, with the most recent change of +$459.00 million (+11.61%) on December 31, 2024.
  • During the last 3 years, REGN annual net income has fallen by -$3.66 billion (-45.36%).
  • REGN annual net income is now -45.36% below its all-time high of $8.08 billion, reached on December 31, 2021.

Performance

REGN Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

quarterly net income:

$808.70M-$109.00M(-11.88%)
March 31, 2025

Summary

  • As of today (May 29, 2025), REGN quarterly net profit is $808.70 million, with the most recent change of -$109.00 million (-11.88%) on March 31, 2025.
  • Over the past year, REGN quarterly net income has increased by +$86.70 million (+12.01%).
  • REGN quarterly net income is now -73.90% below its all-time high of $3.10 billion, reached on June 30, 2021.

Performance

REGN quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

TTM net income:

$4.50B+$86.70M(+1.96%)
March 31, 2025

Summary

  • As of today (May 29, 2025), REGN TTM net profit is $4.50 billion, with the most recent change of +$86.70 million (+1.96%) on March 31, 2025.
  • Over the past year, REGN TTM net income has increased by +$641.50 million (+16.63%).
  • REGN TTM net income is now -44.28% below its all-time high of $8.08 billion, reached on December 31, 2021.

Performance

REGN TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

REGN Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.6%+12.0%+16.6%
3 y3 years-45.4%-16.9%-43.3%
5 y5 years+108.5%+29.5%+97.4%

REGN Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-45.4%+11.6%-43.5%+12.0%-43.3%+16.6%
5 y5-year-45.4%+108.5%-73.9%+29.5%-44.3%+97.4%
alltimeall time-45.4%+2089.8%-73.9%+1393.8%-44.3%+2128.9%

REGN Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
$808.70M(-11.9%)
$4.50B(+2.0%)
Dec 2024
$4.41B(+11.6%)
$917.70M(-31.5%)
$4.41B(-5.2%)
Sep 2024
-
$1.34B(-6.4%)
$4.65B(+7.7%)
Jun 2024
-
$1.43B(+98.4%)
$4.32B(+12.0%)
Mar 2024
-
$722.00M(-37.7%)
$3.86B(-2.4%)
Dec 2023
$3.95B(-8.9%)
$1.16B(+15.1%)
$3.95B(-0.9%)
Sep 2023
-
$1.01B(+4.1%)
$3.99B(-7.2%)
Jun 2023
-
$968.40M(+18.4%)
$4.30B(+2.8%)
Mar 2023
-
$817.80M(-31.7%)
$4.18B(-3.6%)
Dec 2022
$4.34B(-46.3%)
$1.20B(-9.0%)
$4.34B(-19.2%)
Sep 2022
-
$1.32B(+54.4%)
$5.37B(-5.6%)
Jun 2022
-
$852.10M(-12.5%)
$5.69B(-28.3%)
Mar 2022
-
$973.50M(-56.3%)
$7.93B(-1.8%)
Dec 2021
$8.08B(+129.9%)
$2.23B(+36.6%)
$8.08B(+15.4%)
Sep 2021
-
$1.63B(-47.3%)
$7.00B(+12.7%)
Jun 2021
-
$3.10B(+177.9%)
$6.21B(+55.0%)
Mar 2021
-
$1.12B(-3.0%)
$4.00B(+14.0%)
Dec 2020
$3.51B(+66.0%)
$1.15B(+36.5%)
$3.51B(+11.3%)
Sep 2020
-
$842.10M(-6.2%)
$3.16B(+5.8%)
Jun 2020
-
$897.30M(+43.7%)
$2.98B(+30.9%)
Mar 2020
-
$624.60M(-21.1%)
$2.28B(+7.7%)
Dec 2019
$2.12B(-13.4%)
$792.00M(+18.3%)
$2.12B(-1.3%)
Sep 2019
-
$669.60M(+246.8%)
$2.14B(+3.6%)
Jun 2019
-
$193.10M(-58.1%)
$2.07B(-14.8%)
Mar 2019
-
$461.10M(-43.8%)
$2.43B(-0.7%)
Dec 2018
$2.44B(+104.0%)
$820.40M(+38.0%)
$2.44B(+36.0%)
Sep 2018
-
$594.70M(+7.9%)
$1.80B(+13.0%)
Jun 2018
-
$551.40M(+15.4%)
$1.59B(+11.5%)
Mar 2018
-
$478.00M(+175.5%)
$1.43B(+19.1%)
Dec 2017
$1.20B(+33.8%)
$173.51M(-55.3%)
$1.20B(-6.2%)
Sep 2017
-
$388.32M(+0.1%)
$1.28B(+10.7%)
Jun 2017
-
$387.74M(+55.8%)
$1.15B(+19.9%)
Mar 2017
-
$248.93M(-1.6%)
$963.05M(+7.5%)
Dec 2016
$895.50M(+40.8%)
$253.09M(-4.4%)
$895.50M(+12.3%)
Sep 2016
-
$264.80M(+35.0%)
$797.40M(+7.3%)
Jun 2016
-
$196.22M(+8.2%)
$743.00M(+0.2%)
Mar 2016
-
$181.38M(+17.0%)
$741.42M(+16.6%)
Dec 2015
$636.06M(+88.1%)
$154.99M(-26.3%)
$636.06M(+11.4%)
Sep 2015
-
$210.40M(+8.1%)
$571.16M(+28.6%)
Jun 2015
-
$194.64M(+156.0%)
$444.13M(+28.4%)
Mar 2015
-
$76.02M(-15.6%)
$345.84M(+2.3%)
Dec 2014
$338.13M(-18.3%)
$90.09M(+8.1%)
$338.13M(+1.2%)
Sep 2014
-
$83.38M(-13.5%)
$334.21M(-14.8%)
Jun 2014
-
$96.35M(+41.1%)
$392.14M(+2.3%)
Mar 2014
-
$68.31M(-20.7%)
$383.17M(-7.4%)
Dec 2013
$413.74M(-44.9%)
$86.18M(-39.0%)
$413.74M(-48.2%)
Sep 2013
-
$141.31M(+61.7%)
$797.96M(-5.9%)
Jun 2013
-
$87.38M(-11.6%)
$848.13M(+1.3%)
Mar 2013
-
$98.87M(-79.0%)
$837.49M(+11.6%)
Dec 2012
$750.27M(-438.3%)
$470.41M(+145.7%)
$750.27M(+231.4%)
Sep 2012
-
$191.47M(+149.5%)
$226.42M(-925.9%)
Jun 2012
-
$76.74M(+558.7%)
-$27.41M(-83.6%)
Mar 2012
-
$11.65M(-121.8%)
-$166.66M(-24.8%)
Dec 2011
-$221.76M(+112.3%)
-$53.44M(-14.3%)
-$221.76M(+21.2%)
Sep 2011
-
-$62.37M(-0.2%)
-$182.91M(+18.4%)
Jun 2011
-
-$62.51M(+43.9%)
-$154.42M(+31.5%)
Mar 2011
-
-$43.45M(+197.6%)
-$117.39M(+12.4%)
Dec 2010
-$104.47M(+54.0%)
-$14.60M(-56.9%)
-$104.47M(-17.3%)
Sep 2010
-
-$33.88M(+33.0%)
-$126.36M(+35.1%)
Jun 2010
-
-$25.47M(-16.5%)
-$93.50M(+12.7%)
Mar 2010
-
-$30.52M(-16.4%)
-$82.96M(+22.3%)
Dec 2009
-$67.83M(-14.3%)
-$36.49M(+3495.0%)
-$67.83M(+14.4%)
Sep 2009
-
-$1.01M(-93.2%)
-$59.28M(-25.3%)
Jun 2009
-
-$14.94M(-2.9%)
-$79.38M(-4.5%)
Mar 2009
-
-$15.39M(-44.9%)
-$83.13M(+4.8%)
Dec 2008
-$79.13M(-25.1%)
-$27.94M(+32.3%)
-$79.36M(+23.1%)
Sep 2008
-
-$21.11M(+13.0%)
-$64.49M(-18.6%)
Jun 2008
-
-$18.69M(+60.9%)
-$79.22M(-9.3%)
Mar 2008
-
-$11.62M(-11.1%)
-$87.30M(-17.3%)
Dec 2007
-$105.60M
-$13.07M(-63.5%)
-$105.60M(-14.5%)
DateAnnualQuarterlyTTM
Sep 2007
-
-$35.84M(+33.9%)
-$123.50M(+7.3%)
Jun 2007
-
-$26.77M(-10.5%)
-$115.07M(+2.9%)
Mar 2007
-
-$29.92M(-3.4%)
-$111.87M(+9.3%)
Dec 2006
-$102.34M(+7.2%)
-$30.97M(+13.0%)
-$102.34M(+1.3%)
Sep 2006
-
-$27.41M(+16.3%)
-$101.04M(-6.7%)
Jun 2006
-
-$23.58M(+15.7%)
-$108.28M(-3.1%)
Mar 2006
-
-$20.38M(-31.3%)
-$111.70M(+17.0%)
Dec 2005
-$95.45M(-328.9%)
-$29.67M(-14.4%)
-$95.45M(+51.5%)
Sep 2005
-
-$34.65M(+28.3%)
-$62.98M(+59.8%)
Jun 2005
-
-$27.00M(+554.8%)
-$39.41M(+46.2%)
Mar 2005
-
-$4.12M(-247.7%)
-$26.96M(-164.6%)
Dec 2004
$41.70M(-138.8%)
$2.79M(-125.2%)
$41.70M(+113.5%)
Sep 2004
-
-$11.08M(-23.9%)
$19.53M(+509.2%)
Jun 2004
-
-$14.55M(-122.5%)
$3.21M(-125.4%)
Mar 2004
-
$64.53M(-433.0%)
-$12.61M(-88.2%)
Dec 2003
-$107.46M(-13.6%)
-$19.38M(-29.3%)
-$107.25M(-13.2%)
Sep 2003
-
-$27.40M(-9.7%)
-$123.56M(-4.2%)
Jun 2003
-
-$30.36M(+0.8%)
-$128.98M(-0.0%)
Mar 2003
-
-$30.11M(-15.6%)
-$129.04M(+3.8%)
Dec 2002
-$124.38M(+63.3%)
-$35.69M(+8.8%)
-$124.38M(+6.2%)
Sep 2002
-
-$32.82M(+7.9%)
-$117.06M(+12.4%)
Jun 2002
-
-$30.42M(+19.6%)
-$104.18M(+17.6%)
Mar 2002
-
-$25.45M(-10.3%)
-$88.59M(+16.3%)
Dec 2001
-$76.18M(+228.1%)
-$28.38M(+42.4%)
-$76.18M(+35.4%)
Sep 2001
-
-$19.93M(+34.4%)
-$56.26M(+42.6%)
Jun 2001
-
-$14.83M(+13.8%)
-$39.44M(+43.6%)
Mar 2001
-
-$13.04M(+54.2%)
-$27.46M(+26.3%)
Dec 2000
-$23.21M(+0.5%)
-$8.46M(+171.2%)
-$21.75M(+48.0%)
Sep 2000
-
-$3.12M(+9.3%)
-$14.69M(-10.8%)
Jun 2000
-
-$2.85M(-61.0%)
-$16.47M(-23.1%)
Mar 2000
-
-$7.32M(+422.7%)
-$21.42M(-6.9%)
Dec 1999
-$23.10M(+168.6%)
-$1.40M(-71.4%)
-$23.00M(-15.1%)
Sep 1999
-
-$4.90M(-37.2%)
-$27.10M(+14.8%)
Jun 1999
-
-$7.80M(-12.4%)
-$23.60M(+72.3%)
Mar 1999
-
-$8.90M(+61.8%)
-$13.70M(+59.3%)
Dec 1998
-$8.60M(-25.9%)
-$5.50M(+292.9%)
-$8.60M(+230.8%)
Sep 1998
-
-$1.40M(-166.7%)
-$2.60M(-16.1%)
Jun 1998
-
$2.10M(-155.3%)
-$3.10M(-67.4%)
Mar 1998
-
-$3.80M(-860.0%)
-$9.50M(-18.1%)
Dec 1997
-$11.60M(-64.2%)
$500.00K(-126.3%)
-$11.60M(-42.6%)
Sep 1997
-
-$1.90M(-55.8%)
-$20.20M(-25.7%)
Jun 1997
-
-$4.30M(-27.1%)
-$27.20M(-10.8%)
Mar 1997
-
-$5.90M(-27.2%)
-$30.50M(-5.9%)
Dec 1996
-$32.40M(+37.9%)
-$8.10M(-9.0%)
-$32.40M(+0.9%)
Sep 1996
-
-$8.90M(+17.1%)
-$32.10M(+5.9%)
Jun 1996
-
-$7.60M(-2.6%)
-$30.30M(+11.8%)
Mar 1996
-
-$7.80M(0.0%)
-$27.10M(+15.3%)
Dec 1995
-$23.50M(-23.5%)
-$7.80M(+9.9%)
-$23.50M(+9.3%)
Sep 1995
-
-$7.10M(+61.4%)
-$21.50M(+16.8%)
Jun 1995
-
-$4.40M(+4.8%)
-$18.40M(-24.0%)
Mar 1995
-
-$4.20M(-27.6%)
-$24.20M(-21.2%)
Dec 1994
-$30.70M(-23.1%)
-$5.80M(+45.0%)
-$30.70M(-15.7%)
Sep 1994
-
-$4.00M(-60.8%)
-$36.40M(-13.3%)
Jun 1994
-
-$10.20M(-4.7%)
-$42.00M(+1.9%)
Mar 1994
-
-$10.70M(-7.0%)
-$41.20M(+3.5%)
Dec 1993
-$39.90M(+108.9%)
-$11.50M(+19.8%)
-$39.80M(+14.7%)
Sep 1993
-
-$9.60M(+2.1%)
-$34.70M(+12.3%)
Jun 1993
-
-$9.40M(+1.1%)
-$30.90M(+22.6%)
Mar 1993
-
-$9.30M(+45.3%)
-$25.20M(+31.3%)
Dec 1992
-$19.10M(+324.4%)
-$6.40M(+10.3%)
-$19.20M(+28.9%)
Sep 1992
-
-$5.80M(+56.8%)
-$14.90M(+49.0%)
Jun 1992
-
-$3.70M(+12.1%)
-$10.00M(+51.5%)
Mar 1992
-
-$3.30M(+57.1%)
-$6.60M(+50.0%)
Dec 1991
-$4.50M(+36.4%)
-$2.10M(+133.3%)
-$4.40M(+37.5%)
Sep 1991
-
-$900.00K(+200.0%)
-$3.20M(+3.2%)
Jun 1991
-
-$300.00K(-72.7%)
-$3.10M(-13.9%)
Mar 1991
-
-$1.10M(+22.2%)
-$3.60M(+9.1%)
Dec 1990
-$3.30M
-$900.00K(+12.5%)
-$3.30M(+37.5%)
Sep 1990
-
-$800.00K(0.0%)
-$2.40M(+50.0%)
Jun 1990
-
-$800.00K(0.0%)
-$1.60M(+100.0%)
Mar 1990
-
-$800.00K
-$800.00K

FAQ

  • What is Regeneron Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual net income year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly net income year-on-year change?
  • What is Regeneron Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals TTM net income year-on-year change?

What is Regeneron Pharmaceuticals annual net profit?

The current annual net income of REGN is $4.41B

What is the all time high annual net income for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual net profit is $8.08B

What is Regeneron Pharmaceuticals annual net income year-on-year change?

Over the past year, REGN annual net profit has changed by +$459.00M (+11.61%)

What is Regeneron Pharmaceuticals quarterly net profit?

The current quarterly net income of REGN is $808.70M

What is the all time high quarterly net income for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly net profit is $3.10B

What is Regeneron Pharmaceuticals quarterly net income year-on-year change?

Over the past year, REGN quarterly net profit has changed by +$86.70M (+12.01%)

What is Regeneron Pharmaceuticals TTM net profit?

The current TTM net income of REGN is $4.50B

What is the all time high TTM net income for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high TTM net profit is $8.08B

What is Regeneron Pharmaceuticals TTM net income year-on-year change?

Over the past year, REGN TTM net profit has changed by +$641.50M (+16.63%)
On this page